U.S. market Open. Closes in 1 hour 40 minutes

INTS | Intensity Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/AN/AN/A
Cost of Revenue147.00K179.04KN/AN/AN/A
Gross Profit-147.00K-179.04KN/AN/AN/A
Operating Expenses8.17M7.55M8.01M6.22M5.68M
Selling, General & Admin3.39M2.42M2.16M1.17M1.24M
Research & Development4.79M5.13M5.86M5.05M4.44M
Other Operating ExpensesN/A47.65K115.51K118.76K144.99K
Operating Income-8.32M-7.63M-8.01M-6.22M-5.68M
Other Expenses / Income-2.22M49.06K118.12K192.77K295.70K
Before Tax Income-10.54M-7.58M-7.90M-6.03M-5.38M
Income Tax ExpensesN/A-131.91K-2.61K-74.01K-150.71K
Net Income-10.54M-7.45M-7.89M-5.96M-5.23M
Interest Expenses305.00K81.78K16.77KN/AN/A
Basic Shares Outstanding8.62M13.10M13.10M13.10M13.10M
Diluted Shares Outstanding8.62M13.10M13.10M13.10M13.10M
EBITDA-10.09M-7.40M-7.88M-6.03M-5.38M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-10.23M-7.50M-7.88M-6.03M-5.38M
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙